Search Page

1

Cite

Share

STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART.

BRAUNWALD E, CHIDSEY CA, HARRISON DC, GAFFNEY TE, KAHLER RL. BRAUNWALD E, et al. Among authors: gaffney te. Circulation. 1963 Nov;28:958-69. doi: 10.1161/01.cir.28.5.958. Circulation. 1963. PMID: 14079202 Review. No abstract available.

Cite

Share

2

Cite

Share

Stereoselective delivery and actions of beta receptor antagonists.

Walle T, Webb JG, Bagwell EE, Walle UK, Daniell HB, Gaffney TE. Walle T, et al. Among authors: gaffney te. Biochem Pharmacol. 1988 Jan 1;37(1):115-24. doi: 10.1016/0006-2952(88)90763-0. Biochem Pharmacol. 1988. PMID: 2892494 Review.

Cite

Share

3

Cite

Share

Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin.

Atkinson AJ Jr, MacGee J, Strong J, Garteiz D, Gaffney TE. Atkinson AJ Jr, et al. Among authors: gaffney te. Biochem Pharmacol. 1970 Aug;19(8):2483-91. doi: 10.1016/0006-2952(70)90274-1. Biochem Pharmacol. 1970. PMID: 5520606 No abstract available.

Cite

Share

4

Cite

Share

Stereoselective ring oxidation of propranolol in man.

Walle T, Walle UK, Wilson MJ, Fagan TC, Gaffney TE. Walle T, et al. Among authors: gaffney te. Br J Clin Pharmacol. 1984 Nov;18(5):741-8. doi: 10.1111/j.1365-2125.1984.tb02537.x. Br J Clin Pharmacol. 1984. PMID: 6508983 Free PMC article.

Cite

Share

5

Cite

Share

A stereoselective central hypotensive action of atenolol.

Pearson AA, Gaffney TE, Walle T, Privitera PJ. Pearson AA, et al. Among authors: gaffney te. J Pharmacol Exp Ther. 1989 Sep;250(3):759-63. J Pharmacol Exp Ther. 1989. PMID: 2778713

Cite

Share

6

Cite

Share

Stereoselective clearance and distribution of intravenous propranolol.

Olanoff LS, Walle T, Walle UK, Cowart TD, Gaffney TE. Olanoff LS, et al. Among authors: gaffney te. Clin Pharmacol Ther. 1984 Jun;35(6):755-61. doi: 10.1038/clpt.1984.107. Clin Pharmacol Ther. 1984. PMID: 6734027

Cite

Share

7

Cite

Share

Antihypertensive effects of lofexidine in patients with essential hypertension.

Fagan TC, Bloomfield SS, Cowart TD, Corns-Hurwitz RH, Lipicky RJ, Conradi EC, Hsu CY, Grossman WJ, Harmon GE, Degenhart WJ, Sinkfield AW, Gaffney TE. Fagan TC, et al. Among authors: gaffney te. Br J Clin Pharmacol. 1982 Mar;13(3):405-10. doi: 10.1111/j.1365-2125.1982.tb01393.x. Br J Clin Pharmacol. 1982. PMID: 7059442 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

Exercise-induced increments in plasma levels of propranolol and noradrenaline.

Hurwitz GA, Webb JG, Walle T, Bai SA, Daniell HB, Gourley L, Boyd Loadholt C, Gaffney TE. Hurwitz GA, et al. Among authors: gaffney te. Br J Clin Pharmacol. 1983 Dec;16(6):599-608. doi: 10.1111/j.1365-2125.1983.tb02228.x. Br J Clin Pharmacol. 1983. PMID: 6661342 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Cardiovascular actions of a new metabolite of propranolol: isopropylamine.

Ishizaki T, Privitera PJ, Walle T, Gaffney TE. Ishizaki T, et al. Among authors: gaffney te. J Pharmacol Exp Ther. 1974 Jun;189(3):626-32. J Pharmacol Exp Ther. 1974. PMID: 4152314 No abstract available.

Cite

Share

10

Cite

Share

Effect of methyldopa on plasma renin activity in man.

Mohammed S, Fasola AF, Privitera PJ, Lipicky RJ, Martz BL, Gaffney TE. Mohammed S, et al. Among authors: gaffney te. Circ Res. 1969 Nov;25(5):543-8. doi: 10.1161/01.res.25.5.543. Circ Res. 1969. PMID: 4900604 Clinical Trial. No abstract available.

Cite

Share